Boxer Asset Management Amends Tango Therapeutics Stake

Ticker: TNGX · Form: SC 13D/A · Filed: Oct 15, 2024 · CIK: 1819133

Sentiment: neutral

Topics: schedule-13d, amendment, shareholder-activity

Related Tickers: TGTX

TL;DR

Boxer Asset Management filed a 13D amendment on Tango Therapeutics. Watch for potential stock moves.

AI Summary

Boxer Asset Management Inc. filed an amendment (No. 4) to its Schedule 13D on October 15, 2024, regarding its holdings in Tango Therapeutics, Inc. The filing indicates a change in the beneficial ownership of Tango Therapeutics' common stock. Boxer Asset Management Inc. is the filer, with its principal business address located in Lyford Cay, New Providence.

Why It Matters

This filing signals a potential shift in major shareholder influence or strategy for Tango Therapeutics, which could impact its stock price and future corporate actions.

Risk Assessment

Risk Level: medium — Schedule 13D filings often precede significant corporate events or changes in control, introducing uncertainty.

Key Players & Entities

FAQ

What specific change in beneficial ownership is detailed in Amendment No. 4?

The filing is an amendment to Schedule 13D, indicating a change in beneficial ownership, but the specific percentage or number of shares acquired or disposed of is not detailed in the provided header information.

When was this amendment filed with the SEC?

This amendment was filed on October 15, 2024.

Who is the subject company of this filing?

The subject company is Tango Therapeutics, Inc.

Who is the entity filing this Schedule 13D/A?

The entity filing is Boxer Asset Management Inc.

What is the CUSIP number for Tango Therapeutics, Inc. common stock?

The CUSIP number for Tango Therapeutics, Inc. common stock is 87583X109.

Filing Stats: 2,515 words · 10 min read · ~8 pages · Grade level 11.5 · Accepted 2024-10-15 19:25:19

Key Financial Figures

Filing Documents

is hereby amended and restated to read as follows

Item 2 is hereby amended and restated to read as follows: This Schedule 13D is jointly filed by Boxer Management, Braslyn and Mr. Lewis . Boxer Management, a Bahamian international business company, is the managing member and majority owner of Boxer Capital, a limited liability company organized under the laws of Delaware. Braslyn is a corporation organized under the laws of the Bahamas. Mr. Lewis is the sole indirect owner of and controls Boxer Management and Braslyn. Each of Boxer Management and Braslyn are primarily engaged in the business of investing in securities. Mr. Lewis is a citizen of the United Kingdom and his present principal occupation or employment is engaging in business as a private investor including through the investments of Boxer Capital and Braslyn. The address of each of Boxer Management, Braslyn and Mr. Lewis for purposes of this filing is: Albany Financial Center, Suite 207, Lewis Drive, N7776, New Providence, Bahamas. Set forth on Schedule A , and incorporated herein by reference, is the (a) name, (b) residence or business address, (c) present principal occupation or employment and (d) citizenship, of each executive officer and director of each of Boxer Management and Braslyn, and (e) name of any corporation or other organization in which such occupation or employment is conducted, together with the principal business and address of any such corporation or organization other than Boxer Management and Braslyn. Except as set forth on Schedule B to this Schedule 13D, none of the Reporting Persons nor any of the individuals identified on Schedule A to this Schedule 13D has, during the past five years, (a) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or (b) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting,

is hereby amended by the addition of the following

Item 3 is hereby amended by the addition of the following: The disclosure set forth below in Item 4 is hereby incorporated herein. Item 4. Purpose of Transaction.

is hereby amended by the addition of the following

Item 4 is hereby amended by the addition of the following: On October 10, 2024, Boxer Management, Boxer Capital and BCM entered into the IMA, pursuant to which Boxer Capital has delegated exclusive voting and investment power over its investment portfolio to BCM. Consequently, BCM has acquired beneficial ownership of the shares of Common Stock held by Boxer Capital and, without reflecting any change in its economic interest in such securities, Boxer Capital has thereby ceased to beneficially own the securities held in its investment portfolio, including shares of Common Stock. Consequently, each of Boxer Management and Mr. Lewis has ceased to beneficially own the securities held in Boxer Capital's investment portfolio. Item 5. Interest in Securities of the Issuer.

is hereby amended and restated to read as follows

Item 5 is hereby amended and restated to read as follows: All percentages are based on 107,144,465 shares of the Issuer's Common Stock outstanding as of August 1, 2024 as set forth in the Issuer's 10-Q filed with the Securities and Exchange Commission on August 7, 2024. (a) The Reporting Persons may be deemed to beneficially own, in the aggregate, 26,961 shares of Common Stock, representing less than 0.1% of the outstanding shares of Common Stock. (b) With respect to any rights or powers to vote, or to direct the vote of, or to dispose of, or to direct the disposition of, the Common Stock owned by the Reporting Persons: (i) Sole power to vote or to direct the vote: None of the Reporting Persons has the sole power to vote or to direct the vote of shares of the Common Stock. (ii) Shared power to vote or to direct the vote: Braslyn and Mr. Lewis have shared power to vote or to direct the vote of 26,961 shares of Common Stock. (iii) Sole power to dispose or to direct the disposition of: None of the Reporting Persons has the sole power to dispose or direct the disposition of shares of the Common Stock. (iv) Shared power to dispose or to direct the disposition of: Braslyn and Mr. Lewis have shared power to dispose or direct the disposition of 26,961 shares of Common Stock. (c) Other than as described herein in Item 4 or transactions previously reported on Form 4, the Reporting Persons have not engaged in any transactions in the Common Stock in the past 60 days. (d) Not applicable. (e) As described in Item 4, as of October 10, 2024, Boxer Management, Braslyn and Mr. Lewis ceased to beneficially own more than 5% of the outstanding shares of Common Stock. Item 7. Material to be Filed as Exhibits.

is hereby amended by the addition of the following

Item 7 is hereby amended by the addition of the following: Exhibit No. Description Exhibit 3 Joint Filing Agreement, dated October 15, 2024, among Boxer Management, Braslyn and Mr. Lewis.

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: October 15, 2024 BOXER ASSET MANAGEMENT INC. By: /s/ Paul Higgs Name: Paul Higgs Title: Director BRASLYN LTD. By: /s/ Paul Higgs Name: Paul Higgs Title: Director JOSEPH C. LEWIS /s/ Joseph C. Lewis Joseph C. Lewis, Individually JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D and any amendments to it with respect to Common Stock, $0.001 par value per share, of Tango Therapeutics, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to those joint filings. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument. Dated: October 15, 2024. BOXER ASSET MANAGEMENT INC. By: /s/ Paul Higgs Name: Paul Higgs Title: Director BRASLYN LTD. By: /s/ Paul Higgs Name: Paul Higgs Title: Director JOSEPH C. LEWIS /s/ Joseph C. Lewis Joseph C. Lewis, Individually SCHEDULE A ADDITIONAL INFORMATION CONCERNING THE REPORTING PERSONS BOXER ASSET MANAGEMENT INC. The executive officers and directors of Boxer Asset Management Inc. are set forth below. Each individual's business address is Albany Financial Center, Suite 207, Lewis Drive, N7776, New Providence, Bahamas. Except as otherwise stated, the present principal occupation or employment set forth below opposite the name of each person refers to employment with Boxer Asset Management Inc . Name

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on Read The Filing